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We have developed a computational strategy to identify the set of soluble proteins secreted into the
extracellular environment of a cell. Within the protein sequences predominantly derived from the RIKEN
representative transcript and protein set, we identified 2033 unique soluble proteins that are potentially
secreted from the cell. These proteins contain a signal peptide required for entry into the secretory pathway
and lack any transmembrane domains or intracellular localization signals. This class of proteins, which we have
termed the mouse secretome, included >500 novel proteins and 92 proteins <100 amino acids in length.
Functional analysis of the secretome included identification of human orthologs, functional units based on
InterPro and SCOP Superfamily predictions, and expression of the proteins within the RIKEN READ microarray
database. To highlight the utility of this information, we discuss the CUB domain-containing protein family.
[Supplemental material is available at www.genome.org.]
The RIKEN Mouse Gene Encyclopedia project aims to identify
the full set of transcripts that are derived from the mouse
genome (The FANTOM Consortium and the RIKEN Genome
Exploration Research Group Phase I and II Team 2002). The
60,770 cDNA clones fully sequenced in the RIKEN project
were selected from 246 full-length, enriched cDNA libraries
derived from a range of tissue sources predominantly from
C57BL/6J mice. This strategy was combined with the removal
of known cDNA clones on the basis of the terminal sequence
that overlaps with other mouse transcript sequences, thus re-
sulting in the identification of a significant number of novel
mouse cDNA sequences including those with tissue-specific
expression patterns. Computational clustering of these cDNA
sequences with related public domain data identified 37,086
unique transcriptional units, termed the representative tran-
script and protein set (RTPS). From the RTPS, 18,768 protein-
coding ORFs, termed the representative protein set (RPS),
were annotated in part by the Mouse Annotation Teleconfer-
ence for RIKEN cDNA sequences (MATRICS) curation process.
However, only 17,209 of the 18,768 RPS entries are estimated
to encode full-length protein ORFs (The FANTOM Consor-
tium and the RIKEN Genome Exploration Research Group
Phase I and II Team 2002).
Proteins that are secreted from cells into the extracellular
media represent the major class of molecules involved in in-
tercellular communication in multicellular organisms, and in
humans, they have additional importance as targets for thera-
peutic intervention in disease. This class of proteins is referred
to as the mouse secretome (Greenbaum et al. 2001). Pro-
teomic approaches to experimentally measure the secretome
to date have detected only a fraction of the proteins secreted
from the cell. For example, proteomic analysis of serum or
plasma has been restricted by the fact that a relatively small
number of proteins represent up to 80% of the protein total
(Georgiou et al. 2001). Furthermore, many secreted proteins
are expressed only by specialized cell types, are expressed only
during specific stages of development, or have an induced
expression during specific cellular responses, including those
in the immune system.
In this study, we used computational approaches to an-
notate the membrane organization of individual full-length
proteins within the RPS from the prediction of endoplasmic
reticulum (ER) signal peptides and membrane spanning do-
mains, with a view to determining the full extent of the
mouse secretome. For the prediction of the membrane orga-
nization within the RIKEN RPS, we used a consensus approach
(The FANTOM Consortium and the RIKEN Genome Explora-
tion Research Group Phase I and II Team 2002) and extended
it to a number of other protein data sets (Kanapin et al 2003).
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This classification scheme allowed for the identification of
soluble proteins that are strong candidates to enter the secre-
tory pathway via the ER. The majority of these soluble pro-
teins are likely be secreted from the cell into the extracellular
environment. The identification of this set of proteins, com-
bined with predicted functions based on functional unit pre-
dictions and with mRNA expression information, provides a
basis for experimental validation and identification of new
molecules involved in intercellular communication.
RESULTS AND DISCUSSION
Defining the Mouse Secretome
The generation of the 2033 protein set that we term the
mouse secretome contains proteins identified from a number
of complementary approaches (Table 1). The majority of se-
quences were derived from the final RIKEN RPS data set (The
FANTOM Consortium and the RIKEN Genome Exploration
Research Group Phase I and II Team 2002; http://
genome.gsc.riken.go.jp), with the remainder identified in the
mouse-integrated protein index (IPI) data set (http://
www.ebi.ac.uk/proteome; Apweiler et al. 2001). Initially, we
collected all of the 2040 RPS “class B” (ER signal peptide posi-
tive/transmembrane domain negative) or soluble secreted
proteins identified during the membrane
organization annotation (Kanapin et al.
2003) and an additional 43 class B se-
quences from the mouse IPI that were not
represented in the RPS data set. We ex-
cluded all of the IPI class B sequences that
showed >99% identity to an RPS class B
protein sequence. For the remaining IPI
sequences, we excluded those that en-
coded partial or full ORFs that had iden-
tity to segments of RTPS transcript se-
quences. Each of the remaining IPI se-
quences was analyzed using TBLASTN
searches against the RTPS data. In addi-
tion, hypothetical proteins from EN-
SEMBL gene predictions and sequences
annotated as fragments were discarded
because of the low reliability of the pro-
tein ORF representing a full-length se-
quence. IPI sequences related to immune
proteins generated through genomic re-
combination events (i.e., T cell receptors
and immunoglobulins) were also dis-
carded. These 2083 class B representative
sequences were further considered as can-
didates for inclusion within the mouse
secretome.
The initial analysis for ORFs in the 60,770 FANTOM2
clone set, using the PROCREST algorithm, identified a large
number of cDNAs with a small ORF of <99 amino acids in
length. These short ORFs would have been automatically ex-
cluded from the annotation pipeline in order to minimize the
description of false coding sequences. However, we consid-
ered this group of sequences relevant because of the numer-
ous known examples of secreted proteins that are <99 amino
acids in length. Analysis of all of the 60,770 PROCREST pre-
dicted ORFs from the FANTOM2 clone set for their membrane
organization identified 4304 cDNAs that contained a putative
ORF and that were predicted to encode a secreted class B mol-
ecule (Fig. 1). Because 724 of these ORFs were between 50 and
99 amino acids in length, we therefore expanded our analysis
to include all clones encoding secreted molecules of 50–99
amino acids.
One reason for the large number of predicted putative
short secreted proteins was that several mouse DNA repeat
sequences, when translated, encode for protein sequences
that are predicted to be signal peptides. These were frequently
selected as the putative ORF by PROCREST when a better al-
ternative was not present. Therefore, we undertook a rigorous
review of all small class B cDNAs (see Table 2). In order to
minimize the annotation of false ORFs, the following criteria
were adopted for analyzing these clones. First, clones with
5UTRs of >500 bp were excluded because longer 5UTRs
would be significantly greater than the calculated average
length of 5-UTR regions (240 bp; International Human Ge-
nome Sequencing Consortium 2001). Second, we analyzed
the sequence upstream from the putative initial codon and
any overlapping cDNAs documented in the FANTOM2 data-
base (Kasukawa et al. 2003) to ensure that the proposed ORF
was not a partial truncated ORF within a non-full-length tran-
script. Third, cDNA sequences found to be containing DNA
repeat sequences throughout the ORF were excluded. cDNA
sequences that failed any one of these criteria or represented
redundant identical sequences were removed.
Table 1. Origin of Proteins Within the Mouse Secretome
“Class B” protein sequences derived from the RPS 2040
“Class B” protein sequences derived from the mouse IPI
(not represented in RPS) 43
Total number of “Class B” proteins 2083
“Class B” protein sequences <100 amino acids not
well supported 18
“Class B” protein sequences predicted to be retained
in the endoplasmic reticulum 32
Total number of proteins within the mouse secretome 2033
Figure 1 Size distribution of the proteins predicted to contain endoplasmic reticulum signal
peptides within the PROCREST predicted ORFs of the RIKEN 60,770 FANTOM2 cDNA clone set
and the mouse secretome. The total numbers of proteins within 50 amino acid blocks are
plotted.
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The remaining clone set was then reviewed for several
characteristics that would lend support to them encoding a
bona fide gene product. These included (1) the reliability of
the ORF prediction. We required that the PROCREST ORF pre-
diction algorithms agreed with at least one of the additional
ORF prediction algorithms used during FANTOM2 annota-
tion; (2) the presence of a domain as determined by InterPro
(Apweiler et al. 2000) and SCOP Superfamily predictions
(Gough and Chothia 2002); (3) the presence of intron and
exon structure as defined by Genomapper; (4) the presence of
independent ESTs to support the validity of the transcript; (5)
the presence of an orthologous gene product; and (6) evi-
dence of gene expression by DNA microarrays. All of this an-
notation was performed using the FANTOM2 interface. Each
clone was evaluated using all the preceding lines of evidence.
Only clones with several lines of positive evidence were in-
cluded. Forty-one FANTOM2 cDNAs of the 741 signal peptide
positive ORFs of <99 amino acids passed these restrictions.
This was performed prior to the generation of the RTPS; there-
fore, these 41 FANTOM2 cDNAs are included in the RTPS (The
FANTOM Consortium and the RIKEN Genome Exploration
Research Group Phase I and II Team 2002).
Twenty-four cDNAs that met these criteria were known
genes, the majority of which were small signaling molecules
(e.g., Neuropeptide Y, the small inducible cytokine family). A
further 17 novel cDNAs were also identified (see Table 3). Six
of these novel cDNAs encode proteins structurally related to
the defensin/cryptdin class of small cationic peptides in-
volved in antimicrobial activities (White et al. 1995). These
clones were annotated as part of the MATRICS annotation
and were included in the RPS set. The final RPS data contained
107 class B proteins of <100 amino acids in length. The addi-
tional class B proteins were contributed to the RPS from the
public data (RefSeq and SWISS-PROT). In addition, three pro-
teins of <100 amino acids from the IPI were identified using
the same approach. Eighteen of these additional 69 proteins
of <100 amino acids were excluded based on the same criteria
as for the RIKEN FANTOM2 proteins. Finally, 92 proteins of
<100 amino acids were included in the secretome, which in-
cluded 67 proteins of known function.
Also included in the class B protein set are the signal
peptide positive soluble proteins that remain associated with
the cell. These include proteins with a subcellular localization
including the ER, Golgi, secretory granules, and the endo-
somal system. Both the proteins within secretory granules
and the endosomal system can be considered part of the sec-
retome. The proteins stored in the secretory granule are des-
tined to be released to the extracellular media, and endosomal
proteins are frequently found within the extracellular media
and can be recognized there by cell surface receptors.
Soluble protein residents within the Golgi and ER ideally
need to be excluded from the secretome. Few examples of
soluble Golgi residents are known (Gleeson 1998), whereas
the ER resident soluble proteins are typically localized via a
sorting signal Lys-Asp-Glu-Leu (KDEL) at their carboxyl ter-
minus (Pelham 1990). Thirty-two class B proteins contained
the KDEL motif and these were not included in the mouse
secretome.
In summary, the 2083 class B representative mouse pro-
Table 2. Origin of RPS Proteins Less Than 100 Amino Acids
Within the Mouse Secretome
“Class B” protein sequences <100 amino acids
within PROCREST predictions from FANTOM2 741
“Class B” protein sequences <100 amino acids
within PROCREST predictions from FANTOM2
with supporting lines of evidence 41
“Class B” protein sequences <100 amino acids not
represented within the PROCREST predictions
from FANTOM2 69
“Class B” protein sequences <100 amino acids not
represented within the PROCREST predictions
from FANTOM2 but possessing supporting lines of
evidence 51
Total number of proteins within the mouse secretome
<100 amino acids 92
Table 3. Novel Predicted Secreted Molecules Between 50 and 99 Amino Acids in Length Within the FANTOM2 Clone Set
RPS CloneID Description Expression
PC15932 0610030I09 Weak defensin-like Kidney, macrophagea
PC9627 1110029C01 Hypothetical protein Muscleb
PC11375 1700007F22 Weakly similar to ACROSIN-TRYPSIN INHIBITOR II PRECURSOR
(HUSI II; SERINE PROTEASE INHIBITOR KAZAL-TYPE 2; (Homo sapiens)
Heartb
PC10965 1700029I15 Hypothetical protein Testisb
PC9896 1700049M11 Elafin-like Testisa
PC8299 2010016B13 Similar to CRYPTDIN-4 (Mus musculus) S. Intestineb
PC9721 2010206A06 Similar to CRYPTDIN-4 (Mus musculus) S. Intestineb
PB11035 2310016C08 Similar to HYPOXIA-INDUCIBLE PROTEIN 2 (Homo sapiens) Multiple tissuesa
PB18873 2510003G01 Hypothetical protein Brainb
PC15487 4930474M22 Hypothetical protein Testisa
PC33926 4930571K11 Hypothetical protein Testisa
PC17718 9230102D03 Weak defensin-like Epididymis, colona
PC17719 9230103N16 Weak defensin-like Epididymis, colona
PC34644 9230118I06 Weak defensin-like Epididymis, spleena
PC17518 9530002K18 Hypothetical Kazal-type serine protease inhibitor domain-containing protein Bladdera
PC27395 A530065I17 Weak immunoglobulin Multiple tissuesa
PC18660 C630041L24 Ovomucoid/PCI-1-like inhibitors Multiple tissuesa
aEST distribution.
bREAD microarray database expression.
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teins that are predicted to encode an ER signal peptide and
not predicted to encode for any transmembrane domains
were further analyzed for inclusion in the mouse secretome.
First, proteins of <100 amino acids in length were critically
assessed to remove those that had a low probability of being
genuine transcripts. Second, proteins that contained intracel-
lular localization signals and were therefore predicted not to
be secreted were removed. The final num-
ber of proteins in the mouse secretome is
2033; therefore, the secretome represents
∼12% of the currently identified mouse
proteome.
Although the criteria we have used
will capture the majority of secreted pro-
teins, additional sources of extracellular
proteins are known. First, an alternative
signal peptide-independent mechanism of
protein secretion is known (Hughes 1999).
Proteins that use the nonclassical secre-
tion pathway include the galectins, FGF-2,
interleukin-1, and thioredoxin. These
proteins may exit the cell through direct
transport from the cytoplasm across the
plasma membrane to the extracellular me-
dia via ATP-binding cassette transporters
(Cleves et al. 1996; Hughes 1999). Second,
a number of transmembrane proteins are
posttranslationally proteolytically cleaved
within their lumenal domains. This results
in soluble proteins that are then secreted
into the extracellular media. Examples in-
clude the type II membrane proteins, tu-
mor necrosis factor-alpha (Shurety et al.
2000), and various glycosyltransferases.
Third, cytoplasmic proteins may be non-
specifically or specifically transported to
the extracellular media via several cellular
processes, like the generation of exosomes
(Thery et al. 2002), or released as a result of
cell death. No current computational ap-
proaches exist to identify these alternative
sources of secreted proteins. In addition,
because they exist both in the intracellular
and extracellular environments, the
known examples have not been included
in the mouse secretome protein set.
A number of sources exist for false-
positive prediction of individual proteins
that should not be included in the mouse
secretome. Signal peptides are also used
for import into other intracellular organ-
elles such as mitochondria and peroxi-
somes. These have some properties in
common with ER signal peptides, and,
along with N-terminal transmembrane an-
chors, are frequently annotated as signal
peptides. To date no definitive computa-
tional methods are able to differentiate be-
tween these classes of sequences, and this
represents an issue that needs to be re-
solved (Chen and Rost 2002). The accu-
racy of the assignment of a protein to the
secretome using this approach is also to-
tally dependent on having the full-length
ORF. If a partial ORF is used, for example, from an inaccurate
ab initio gene prediction, it may lack additional sequence that
could encode for a transmembrane domain or alternatively
not contain the true N terminus that may encode for a signal
peptide. For this reason, extreme caution needs to be taken
with hypothetical protein sequences generated from non-
RNA transcript sources like EST clustering and gene predic-
Figure 2 Distribution of InterPro domains and SCOP superfamilies associated with the mouse
secretome. The proportion of individual InterPro domains (A) or SCOP superfamilies (B) within
the mouse secretome relative to the total number of predicted domains within the RPS is
plotted as a percentage ratio (Secretome/RPS). One hundred percent represents a domain that
is only contained in proteins within the mouse secretome. All RPS protein sequences that could
not be classified by the membrane organization methods were excluded (Kanapin et al. 2003).
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tions within genomic sequences. Only through the genera-
tion and sequencing of full-length cDNAs on a large scale,
such as that conducted by RIKEN, has this type of analysis
been allowed to be performed.
Properties of the Mouse Secretome
Having defined the secretome, we next analyzed it using simi-
lar methods to that used for the entire RPS set (The FANTOM
Consortium and the RIKEN Genome Exploration Research
Group Phase I and II Team 2002).
Novel Proteins Within the Mouse Secretome and the Identification
of Human Orthologs
In an attempt to determine the unique sequence information
within the mouse secretome, we have compared it to public
mouse and human IPI databases. Orthologous human se-
quences were identified using BLASTP (E < e-50
with at least 80% coverage) and identical mouse
sequences were identified using BLASTP (>99%
identity and >99% coverage). Of the protein se-
quences within the mouse genome, 1242 had
clear human orthologs in the human IPI, and
1511 mouse secretome proteins had identical se-
quences within the mouse IPI data set. In addi-
tion, 578 of the RTPS sequences originated from
the FANTOM2 clone set, indicating that these
contained some additional unique sequence in-
formation.
Functional Units Associated With the Mouse Secretome
We determined the InterPro domains (Apweiler
et al. 2000) and SCOP Superfamily (Gough et al.
2001;Gough andChothia 2002) predictions pres-
ent in each protein of the mouse secretome
(Table 4). For the InterPro domain predictions,
1527 (75%) of the mouse secretome had matches
and 693 domains were represented. For the
SCOP Superfamily predictions, 1394 (66%) of
the mouse secretome had matches and 304 su-
perfamilies were represented. In addition, for
each InterPro domain or SCOP Superfamily rep-
resented in the secretome, we determined if it
was unique to the secretome by comparing these
results to those predicted for the entire RPS pro-
teome (Fig. 2, Table 5). We removed the predic-
tions from all RPS protein sequences that were
not full length or could not have their mem-
brane organization annotated (Kanapin et al.
2003). Of the 693 InterPro domains that were
represented in the secretome, 241 (35%) were ex-
clusively found within the secretome proteins
(Fig. 2). Similar results were found for SCOP Su-
perfamily predictions. The presence of these pre-
dictable features within a protein sequence could
represent an alternative approach to identifying
putative secretome proteins, in particular within
partial ORFs.
Domain Combinations
Protein function commonly derives from combi-
natorial actions of distinct domains. To survey
the complexity of the secretome, we examined
the number of predicted domain combinations
in the protein set. Within this analysis, we did
not consider the number of domains present within an indi-
vidual protein, and multiple copies of the same domain were
considered as one. For the InterPro domain predictions and
SCOP superfamily predictions, 498 and 169 distinct combi-
nations, respectively, were observed. In addition, 286 InterPro
domains and 202 SCOP superfamily domains were repre-
sented as single domains.
Biological Processes Associated With the Secretome
To summarize the biological processes associated with the sec-
retome, we adapted the broad domain-based cellular pro-
cesses classification used for the human genome (Venter et al.
2001). We classified various InterPro domains represented
within the mouse secretome into those broad cellular pro-
cesses associated with the extracellular media (see Fig. 3). The
five categories were (1) hemostasis, (2) immune, (3) develop-
Table 4. Top 20 InterPro Domains and SCOP Superfamily Hits for the
Mouse Secretome
InterPro Domains
Domain No. Description
IPR000561 103 EGF-like domain
IPR001254 101 Serine protease, trypsin family
IPR001314 97 Chymotrypsin serine protease, family S1
IPR003599 63 Immunoglobulin subtype
IPR003006 60 Immunoglobulin/major histocompatibility complex
IPR001687 57 ATP/GTP-binding site motif A (P-loop)
IPR001881 54 EGF-like calcium-binding
IPR000087 53 Collagen triple helix repeat
IPR000152 42 Aspartic acid and asparagine hydroxylation site
IPR000379 41 Esterase/lipase/thioesterase, active site
IPR001611 31 Leucine-rich repeat
IPR001811 31 Small chemokine, interleukin-8-like
IPR001839 31 Transforming growth factor beta (TGFb)
IPR003598 31 Immunoglobulin C-2 type
IPR001128 30 Cytochrome P450
IPR003591 29 Leucine-rich repeat, typical subtype
IPR000130 26 Neutral zinc metallopeptidase
IPR000884 25 Thrombospondin, type I
IPR001304 25 C-type lectin
IPR001438 25 Type II EGF-like signature
SCOP Superfamilies
Domain No. Description
50494 98 Trypsin-like serine proteases
57196 90 EGF/laminin
48726 87 Immunoglobulin
47266 52 4-helical cytokines
57501 51 Cystine-knot cytokines
53474 46 alpha/beta-Hydrolases
52540 34 P-loop containing nucleotide triphosphate hydrolases
49899 33 Concanavalin A-like lectins/glucanases
56436 33 C-type lectin-like
54117 31 Interleukin 8-like chemokines
48264 29 Cytochrome P450
55486 26 Metalloproteases (zincins), catalytic domain
53300 24 Integrin A (or I) domain
50814 23 Lipocalins
53448 23 Nucleotide-diphospho-sugar transferases
57392 23 Defensin-like
57467 23 Ovomucoid/PCI-1 like inhibitors
54001 23 Cysteine proteinases
57535 22 Complement control module/SCR domain
49842 21 TNF-like
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mental and homeostatic regulators, (4) proteolysis, and (5)
extracellular matrix and adhesion. Initially, we identified In-
terPro domains that matched the original PFAM domains
used for the human genome and supplemented each category
with additional InterPro domains that had multiple hits
within the secretome. We were able to associate 900 of the
1527 secretome proteins that contained an InterPro domain
to one of these categories. In addition, we analyzed and
compared the subset of mouse secretome proteins to the en-
tire RPS using the same Gene Ontology methodology (The
FANTOM Consortium and the RIKEN Genome Exploration
Research Group Phase I and II Team 2002). As expected for the
cellular component, the secretome was clearly enriched for
proteins (61%) assigned to the extracellular/extracellular ma-
trix when compared with the entire RPS (20%). Significantly,
lower proportions of secretome proteins, relative to the RPS,
were present in the following assignments in the biological
process (DNA metabolism, RNA metabolism, cell cycle and
proliferation, death and cell organization/biogenesis) and
molecular function (cytoskeletal protein, transcription regu-
lator, receptor, other signal transduction). The only assign-
ment clearly enriched in the secretome was the ligand mo-
lecular function assignment. The observations from the Gene
Ontology analysis are consistent with the known biological
properties associated with the extracellular environment.
Tissue Expression of Secretome Proteins
In addition to compiling domain and homology data for all
secreted molecules in the RTPS, microarray expression profil-
ing for FANTOM cDNAs was extracted from the READS data-
base. Expression data are available for 973 of the RIKEN
cDNAs that encode secretome proteins from 22 pooled mouse
tissues: placenta, spleen, small intestine, colon, stomach,
pancreas, liver, lung, adipose (mesenteric), adipose (epididy-
mal), adipose (dorsal), kidney, muscle, bone, thymus, cere-
bellum (neonate 10 d), cerebellum, brain, uterus, kidney,
heart, testis, and skin (neonate 10 d) using
previously described methods (Miki et al.
2001). Normalized expression data were
subjected to hierarchical clustering in or-
der to identify clusters of genes that dis-
play tissue-restricted expression. The re-
sults are summarized in Figure 4. These
expression data can be interrogated by
searching the READs microarray expres-
sion database (Bono et al. 2002; http://
read.gsc.riken.go.jp/). This analysis re-
vealed a spectrum of expression patterns
ranging from ubiquitous to tissue-
restricted profiles.
Highlights From the Secretome
This study describes the first computa-
tional prediction and annotation of the
proteins that are secreted from the cell
into the extracellular space. The use of
combined genomic and transcriptomic
database mining approaches allowed for
the classification of signal peptide posi-
tive ORFs of 50–99 amino acids as puta-
tive secreted proteins. Bioinformatic iden-
tification of this class of gene products has
not been attempted previously, because
computational analysis of genomic DNA sequences has been
limited to ORFs of 100 amino acids or greater, to avoid spu-
rious ORFs from poor gene predictions. The validity of this
approach was supported by the identification of numerous
known short secreted molecules. Many of these short se-
quences were validated transcripts in that they displayed a
tissue-restricted pattern, either by microarray expression pro-
filing or multiple representation of ESTs.
Expression profiling of the secretome and clustering
analysis revealed several groups of genes that were highly ex-
pressed in a tissue-restricted fashion. In addition, for the ma-
jority of tissues, we could readily identify individual secreted
proteins that appear to be expressed exclusively by the one
tissue (Fig. 4A). This highlights the fact that the maintenance
of these tissues and the specialized biological functions asso-
ciated with them require distinct secreted proteins. The larg-
est single cluster was 43 cDNAs, representing 40 genes that
displayed a neural-restricted expression pattern (brain, neo-
natal cerebellum, adult cerebellum) (Fig. 4 Cluster A). The
majority of these genes encode known neural-specific signal-
ing molecules (see Gustincich et al. 2003, for more details).
Other major clusters (Fig. 4 Cluster B-D) of secreted proteins
were expressed in tissues of the placenta, digestive tract, and
testis. As expected, a review of the known genes described
within the digestive cluster revealed large numbers of en-
zymes associated with digestion (peptidase, colipases elasta-
ses, etc.). This combination of predicting secreted molecules
and microarray expression profiling has rapidly defined im-
portant new tissue-specific secreted cell factors.
As described previously, the presence of InterPro and
SCOP domains within the amino acid sequences of every rep-
resentative of the RPS has been recorded. These data can be
used to categorize the families of secreted molecules with re-
spect to molecular functions. In order to highlight the utility
of this information for proteins within the mouse secretome,
we have selected the CUB domain protein family (Bork and
Beckmann 1993) to examine in detail.
Figure 3 Gene Ontology classification of the proteins within the mouse secretome.
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Figure 4 Hierarchical clustering of gene expression data for 970 FANTOM2 cDNAs encoding secretome proteins across 22 mouse tissues. Results
are presented in a dendrogram displaying related groups of genes (on the Y-axis) and tissues (on the X-axis). The relative expression of each cDNA
is represented as a log2 ratio of hybridization signals between each tissue and a common reference mRNA sample (total 17.5 dpc mouse embryo).
Blocks of red signal indicate high levels of expression in the tissue relative to the reference RNA. Blocks of green signify low levels of expression
relative to the reference RNA. Grey blocks indicate data points that are missing. Along the right-hand side of the dendrogram are several yellow
boxes labeled A to D, which define the location of four tissue-restricted clusters. (A) Neural restricted cluster. (B) Placenta cluster. (C) Digestive tract
cluster. (D) Testis cluster.
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Figure 5 Classification of domain architecture in CUB domain-containing proteins. (A) Graphic depiction of domain organization of the
CUB-containing proteins. The 33 proteins analyzed include PC23894, hypothetical CUB-serine protease family (S1)-containing protein; PC15512,
hypothetical Sushi domain-containing protein; PC12522, hypothetical Speract receptor (Scavenger receptor), CUB domain-containing protein;
PB7569, Cegp1 protein; PB8024, signal peptide, CUB domain, EGF-like 1; PA1005, bone morphogenetic protein 1; PB5671, tolloid-like; PB6268,
tolloid-like 2; PB6857, complement component 1, r subcomponent; PA3595, complement-activating component of ra-reactive factor; PC39138,
hypothetical EGF-CUB-Sushi-Serine protease domain-containing protein; PC38939, similar to complement component 1, s subcomponent;
PC40559, similar to complement component 1, s subcomponent; PB3596, mannan-binding lectin serine protease 2; PA5693, tumor necrosis
factor-inducible protein tsg-6; PA4207, procollagen c-proteinase enhancer protein (PCPE); PC16805, procollagen c-terminal proteinase enhancer
protein 2; PC12829, platelet-derived growth factor-C; PB7152, platelet-derived growth factor-D, PC31766, hypothetical CUB domain-containing
protein; PA4026, Neuropilin-1; PA4027, Neuropilin-2; PB19077, kringle-coding gene; PB1500, crp-ductin; PC21298, hypothetical LDLRA-CUB
domain-containing protein; PB8052, low-density lipoprotein receptor-related protein 10; PB19224, CUB and Sushi multiple domains 1; PC24046,
similar to type I transmembrane receptor (seizure-related protein); PB5075, seizure-related gene 6; PB8627, RIKEN cDNA 4631413K11; PC12799,
hypothetical serine protease, trypsin family-containing protein; PA4536, suppressor of tumorigenicity 14; PC15176, hypothetical LDLRA-CUB
domain-containing protein. (B) Key for InterPro domains.
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The CUB domain protein motif was originally found in
the complement subcomponents C1s and C1r. It is an extra-
cellular domain that is thought to mediate protein–protein
interactions and has been found in many proteins with a
developmental function (Bork and Beckmann 1993; Grim-
mond et al. 2000, 2001). Within the RIKEN RPS, 36 nonre-
dundant sequences contain the CUB domain (Fig. 5). Twenty-
four of these genes were known previously to encode CUB
domains. Twelve novel CUB-containing proteins were identi-
fied. Analysis of the membrane organization of this family
predicted that they associate with all membrane classes (Fig.
5; Kanapin et al. 2003).
A study of InterPro domain content and organization of
all CUB proteins was performed. Several observations were
made. First, CUB-containing proteins can be divided into
clusters from the domain architecture (see Fig. 5). Eight do-
mains were observed in the 18 secreted CUB pro-
teins (Netrin, EGF, Sushi, PDGF, Serine protease,
Astacin, and Speract receptor). Although two of
these domains (Sushi and Serine protease) were
also observed in CUB proteins predicted to local-
ize to the membrane, it is clear that organization
of these domains is characteristic of the cellular
compartment the gene products reside in.
Two of the CUB-containing proteins shown
in Figure 5 were predicted to be intracellular
molecules. A reassessment of the annotation of
the proposed ORFs for these two clones, with the
knowledge of the domain combinations and
membrane organization within the CUB family
indicated that they encode partial open reading
frames. PC23894 appeared to be a partial cDNA
with a truncated 5 region and PC15512 ap-
peared to be a pre-mRNA containing at least one
unspliced intron. This review of the domain con-
tent and sequence homology of these clones in-
dicates that the genes, from which partial ORFs
PC23894 and PC15512 were derived, encode a
secreted protein (combination of serine protease
and CUB domains) and a type I membrane pro-
tein (CUB–SUSHI combination, similar to
PB19224), respectively.
The domain combinations associated with
CUBs indicate two major functional groups for
these molecules: (1) protein or ligand binding
(from EGFs, LDLRA, Sushi, FA58C, Speract, and
MAM domains) or (2) proteolytic activity (Asta-
cin, trypsin–serine protease). Furthermore, do-
main usage and organization among the CUB
proteins were associated with subcellular local-
ization and architecture. Finally, the presence of
domain architecture can provide insights into
predicting the localization of truncated ORFs en-
coding CUB proteins or proteins for which sub-
cellular localization is ambiguous to predict.
Summary
The availability of extensive mouse transcrip-
tome full-length cDNA sequences generated by
the RIKEN GSC and incorporation of this infor-
mation into the representative transcript/
protein set (RTPS) has allowed for the prediction
of soluble proteins exported from the cell using
various computational approaches. The set of
2033 mouse secretome proteins contains a large number of
novel or partially characterized proteins. For example, 578
protein sequences were derived from the RIKEN RTPS and 392
proteins lacked any predictable protein properties (Table 6).
The set of secreted proteins represents one biological sys-
tem that has clearly expanded in higher eukaryotes and con-
tains many unique proteins not seen in lower eukaryotes (Ka-
napin et al. 2003). Several major cellular processes are associ-
ated with the proteins that make up the mouse secretome,
including: (1) cell–cell communication via soluble morpho-
gens and growth factors required for tissue development and
cellular differentiation; (2) proteins associated with the im-
mune system including cytokines and antimicrobial agents;
and (3) various proteins associated with the extracellular ma-
trix. Overall this set of proteins represents a resource for the
identification of novel proteins that associate with these criti-
Table 5. Top 20 InterPro Domains and SCOP Superfamilies Associated
Exclusively With the Mouse Secretome
InterPro Domains
Domain No. Description
IPR001111 18 Transforming growth factor beta (TGFb), N-terminal
IPR000867 16 Insulin-like growth factor-binding protein, IGFBP
IPR003129 15 Thrombospondin, N-terminal
IPR000827 14 Small chemokine, C-C subfamily
IPR001886 14 Laminin, N-terminal
IPR001134 11 Netrin, C-terminal
IPR002366 11 Alpha defensin
IPR000471 10 Interferon alpha, beta, and delta family
IPR000034 7 Laminin B
IPR000532 6 Glucagon/GIP/secretin/VIP family
IPR001855 6 Beta defensin
IPR003146 6 Carboxypeptidase activation peptide
IPR003990 6 Pancreatitis-associated protein
IPR000098 5 Interleukin-10
IPR001442 5 Type 4 procollagen, C-terminal repeat
IPR002890 5 Alpha-2-macroglobulin, N-terminal
IPR003014 5 N/apple PAN
IPR003367 5 Thrombospondin type 3 repeat
IPR003645 5 Follistatin-like, N-terminal
IPR000074 4 Apolipoprotein A1/A4/E
SCOP Superfamilies
Domain No. Description
57392 23 Defensin-like
53955 9 Lysozyme-like
56994 8 Insulin-like
47162 5 Apolipoprotein
48201 5 Uteroglobin-like
49410 5 Alpha-macroglobulin receptor domain
50242 5 TIMP-like
57414 5 Hairpin loop containing domain-like
51101 4 Mannose-binding lectins
57581 4 TB module/8-cys domain
47686 3 Anaphylotoxins (complement system)
47862 3 Saposin
51294 3 Hedgehog/intein (Hint) domain
55166 3 Hedgehog/DD-pepidase
55895 3 Ribonuclease Rh-like
57603 3 Fibronectin type I module
55545 2 beta-N-acetylhexosaminidase
57190 2 Colipase-like
57283 2 PMP inhibitors
57288 2 Midkine
Grimmond et al.
1358 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on September 30, 2015 - Published by genome.cshlp.orgDownloaded from 
cal cellular processes. The identification and functional char-
acterization of the proteins will have an impact on many as-
pects of biology including the differentiation of stem cells and
the successful engineering of functional tissues. In addition,
the set of secretome proteins and the methods used to define
them will form the foundation for improvements in the al-
gorithms used to detect them, in particular, within the ge-
nomic sequence.
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Table 6. Properties of the 2033 Mouse Secretome Proteins
Secretome protein sequences derived from the RTPS 578
Secretome protein sequences within the IPI mouse
proteome
1511
Secretome protein sequences that have an ortholog in
human (IPI)
1242
Secretome protein sequences that have InterPro hits 1527
Number of domains represented 693
Number of domain combinations 498
Secretome protein sequences with SCOP hits 1394
Number of superfamilies represented 304
Number of superfamily combinations 169
Secretome protein sequences without an InterPro or
SCOP hit
392
The Mouse Secretome
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